Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in NBP — NovaBridge Biosciences

CIK 1214717 BOSTON, MA
Back to NBP Full portfolio

Position in NBP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$134,255
-$35,113 QoQ
Shares Held
68,849
0.0% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 49 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. NBP ranks #427 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in NBP

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $134,255 68,849
2026-03-31 $169,368 68,849
2025-12-31 $179,434 45,084
2025-09-30 $206,244 54,562
2025-06-30 $132,040 54,562
2025-03-31 $18,158 22,037
2024-12-31 $18,731 22,037
2024-09-30 $27,325 22,037
2024-06-30 $57,359 34,347
2024-03-31 $63,885 34,347
2023-12-31 $65,259 34,347
2023-09-30 $45,338 34,347
2023-06-30 $103,334 34,560
2023-03-31 $120,297 34,768
2022-12-31 $224,737 53,765
2022-09-30 $119,939 29,910
2022-06-30 $491,606 43,505
2022-03-31 $2,944,539 181,314
2021-12-31 $8,307,324 175,297
2021-09-30 $11,388,179 157,100
2021-06-30 $11,676,689 139,091
2021-03-31 $508,547 10,492
2020-12-31 $494,697 10,492
2020-09-30 $251,046 5,338